The Role of Machine Learning to Detect Occult Neck Lymph Node Metastases in Early-Stage (T1-T2/N0) Oral Cavity Carcinomas

机器学习在早期(T1-T2/N0)口腔癌隐匿性颈部淋巴结转移检测中的作用

阅读:1

Abstract

OBJECTIVE: Oral cavity carcinomas (OCCs) represent roughly 50% of all head and neck cancers. The risk of occult neck metastases for early-stage OCCs ranges from 15% to 35%, hence the need to develop tools that can support the diagnosis of detecting these neck metastases. Machine learning and radiomic features are emerging as effective tools in this field. Thus, the aim of this study is to demonstrate the effectiveness of radiomic features to predict the risk of occult neck metastases in early-stage (T1-T2/N0) OCCs. STUDY DESIGN: Retrospective study. SETTING: A single-institution analysis (Maxillo-facial Surgery Unit, University of Naples Federico II). METHODS: A retrospective analysis was conducted on 75 patients surgically treated for early-stage OCC. For all patients, data regarding TNM, in particular pN status after the histopathological examination, have been obtained and the analysis of radiomic features from MRI has been extrapolated. RESULTS: 56 patients confirmed N0 status after surgery, while 19 resulted in pN+. The radiomic features, extracted by a machine-learning algorithm, exhibited the ability to preoperatively discriminate occult neck metastases with a sensitivity of 78%, specificity of 83%, an AUC of 86%, accuracy of 80%, and a positive predictive value (PPV) of 63%. CONCLUSIONS: Our results seem to confirm that radiomic features, extracted by machine learning methods, are effective tools in detecting occult neck metastases in early-stage OCCs. The clinical relevance of this study is that radiomics could be used routinely as a preoperative tool to support diagnosis and to help surgeons in the surgical decision-making process, particularly regarding surgical indications for neck lymph node treatment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。